Investor directoryForty51 Ventures
Forty51 Ventures is dedicated to building exceptional biotech companies in Europe with a clear path to the clinic.
The facts
- Typical cheque
- €1M – €10M
- Headquarters
- Basel, Switzerland
- Founded
- 2022
Portfolio companies
More portfolio companies
Mosanna TherapeuticsNeuroluna TherapeuticsMysthera TherapeuticsMelodia TherapeuticsCartilla Therapeutics
Questions founders ask
- How much does Forty51 Ventures typically invest?
- Forty51 Ventures states a typical cheque of €1M – €10M.
- Which stages does Forty51 Ventures invest in?
- Forty51 Ventures invests at Seed and Series A.
- Where is Forty51 Ventures based?
- Forty51 Ventures is headquartered in Basel, Switzerland.
Does Forty51 Ventures fit your round?
In 30 minutes you'll know which funds matter for your round.
Request accessAre you Forty51 Ventures? Tell us what to correct and we will update it — or ask us to remove the entry.